News

Varenicline helps smokers with stably treated depression

View on the News

Trial may be helpful in understanding of non-psychiatrically ill smokers with history of depression

Dr. Vera DePalo

Dr. Vera DePalo, FCCP, comments: Smoking is a habit that contributes to several disease states and many strategies are employed to help with smoking cessation. Practitioners continue to search for the intervention that can aid the patient in success. As with all pharmacologic therapies,the prescriber considers the unintended side effects.
This industry-funded trial may be helpful to the practitioner's understanding of the possible options in non-psychiatrically ill smokers with a history of depression.


 

FROM ANNALS OF INTERNAL MEDICINE

*CORRECTION, 10/10/13: An earlier version of this article misstated the citation for the journal article referenced in the story.

Pages

Recommended Reading

Suicide risk in the military similar to that in civilian populations
MDedge Psychiatry
CRTC1 polymorphisms affect BMI, novel study finds
MDedge Psychiatry
Pediatric-onset FAP increases persistent anxiety, depression risk
MDedge Psychiatry
Depression, some antidepressants linked to high C. difficile risk
MDedge Psychiatry
Depression linked to accelerated cognitive decline in diabetes
MDedge Psychiatry
Obsessed with Facebook
MDedge Psychiatry
Recommendations for lab monitoring of atypical antipsychotics
MDedge Psychiatry
Depression in pediatric SLE matches average rates
MDedge Psychiatry
Depression, anxiety common in SLE patients
MDedge Psychiatry
Misdiagnosing bipolar depression as major depressive disorder
MDedge Psychiatry